Jonathan Parr is an Infectious Disease physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 194 publications with 3,202 citations (h-index 32).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
101 Manning Dr
Unc Division Of Infectious Diseases
Chapel Hill, NC 27514
Telephone
919-966-7198Registry record last updated 3 Apr 2019.
Medicare prescribing footprint (2019)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
82.9%Glycopeptide Antibacterial23.2%Vancomycin Hcl100%Part D<11 patientsPenicillin-class Antibacterial17.1%Ampicillin Sodium100%Part D<11 patients+ 3 more classes in this area
Cardiovascular
17.1%Statin17.1%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
Univ of North Carolina Chapel Hill
FY2026$639,084R01AI177791 - Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
Univ of North Carolina Chapel Hill
FY2026$86,691R01AI177791 - Epidemiology and determinants of emerging artemisinin-resistant malaria in Ethiopia
Univ of North Carolina Chapel Hill
FY2026$82,080R01AI177791
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rising prevalence of Plasmodium falciparum Artemisinin partial resistance mutations in Ethiopia
Communications Medicine
2025 - Sensitive and modular amplicon sequencing of <i>Plasmodium falciparum</i> diversity and resistance for research and public health
bioRxiv (Cold Spring Harbor Laboratory)
2024 - Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
Nature Microbiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Douglas Drossman, MD
University of North Carolina at Chapel Hill
Michael Knowles, MD
University of North Carolina at Chapel Hill
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”